5Passmore S J, Chessells JM, Kempski H, Hann IM, Brownbill PA Stiller CA. Paediatric myelodysplastic syndromes and juvenile my elomonocytic leukaemia in the UK : a population-based study of in cidence and survival[J]. Br J Haematol, 2003, 121 (5) : 758 767.
6Hasle H, Niemeyer CM, Chessells JM, Baumann I, Bennett JM, Kerndrup G, et al. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases [J]. Leukemia, 2003, 17(2) : 277-282.
7Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Poiwit A, et al. The 2008 revision of the World Health Organization(WHO) classification of myeloid neoplasms and acute leukemia : rationale and important changes [J]. Blood, 2009, 114 (5) :937-951.
8Gologan R. Epidemiological data on myelodysplastic syndrome patients under 50 years in a single center of Romania [ J ]. Leuk Res, 2010, 34(11) : 1442-1446.
9Sasaki H, Manabe A, Kojima S, Tsuchida M, Hayashi Y, Ikuta K, et al. Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan [ J ]. Leukemia, 2001, 15 ( 11 ) : 1713-1720.
10McKenna RW. Myelodysplasia and myeloproliferative disorders in children [J]. Am J Clin Pathol, 2004, 122(Suppl) : 58-69.
